QRG Capital Management Inc. Has $2.63 Million Stock Holdings in Haleon PLC Sponsored ADR $HLN

QRG Capital Management Inc. decreased its stake in Haleon PLC Sponsored ADR (NYSE:HLN) by 42.9% in the third quarter, Holdings Channel reports. The institutional investor owned 292,778 shares of the company’s stock after selling 220,384 shares during the quarter. QRG Capital Management Inc.’s holdings in Haleon were worth $2,626,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of HLN. Arlington Partners LLC acquired a new position in Haleon in the second quarter worth approximately $2,315,000. Scharf Investments LLC acquired a new position in shares of Haleon during the 2nd quarter worth $5,096,000. New York State Common Retirement Fund bought a new position in shares of Haleon during the 2nd quarter valued at $3,964,000. Archford Capital Strategies LLC acquired a new stake in shares of Haleon in the 3rd quarter valued at $2,149,000. Finally, Acadian Asset Management LLC increased its position in Haleon by 3,031.5% during the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock worth $55,813,000 after buying an additional 5,212,711 shares during the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on HLN. Deutsche Bank Aktiengesellschaft cut Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Haleon has an average rating of “Hold” and a consensus target price of $12.33.

Haleon Stock Performance

HLN opened at $9.84 on Tuesday. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average price is $9.82 and its two-hundred day moving average price is $9.60. The firm has a market capitalization of $43.82 billion, a P/E ratio of 25.23 and a beta of 0.19. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.